Deferred Tax Assets, Operating Loss Carryforwards of Renalytix plc from 30 Jun 2018 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Renalytix plc quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Jun 2018 to 30 Jun 2024.
  • Renalytix plc Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Jun 2024 was $45,962,000, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Renalytix plc Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $45,962,000 +$8,222,000 +22% 30 Jun 2024 10-K 30 Sep 2024 2024 FY
Q2 2023 $37,740,000 +$10,539,000 +39% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q2 2022 $27,201,000 +$13,710,000 +102% 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q2 2021 $13,491,000 +$9,195,000 +214% 30 Jun 2021 20-F 31 Oct 2022 2022 FY
Q2 2020 $4,296,000 +$2,464,000 +134% 30 Jun 2020 20-F 31 Oct 2022 2022 FY
Q2 2019 $1,832,000 +$1,669,000 +1024% 30 Jun 2019 20-F/A 01 Aug 2022 2021 FY
Q2 2018 $163,000 30 Jun 2018 20-F/A 10 Nov 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.